MCC
IMGN

Money Concepts Capital’s Immunogen Inc IMGN Stock Holding History

Money Concepts Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-156
Closed -$1K – 2737
2022
Q1 		$1K Buy
+156
New +$864 ﹤0.01% 2635

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Money Concepts Capital's IMGN Position: Q2 2022 in Review

Money Concepts Capital sold out of Immunogen Inc (IMGN) in Q2 2022, closing a stake of 156 shares — an estimated $1K sold.

Money Concepts Capital first reported a position in IMGN in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 216 funds tracked by Wall St. Rank hold IMGN as of Q2 2022.

  • Money Concepts Capital reported no remaining Immunogen Inc position as of Q2 2022 after selling out during the quarter.
  • Money Concepts Capital sold 156 Immunogen Inc shares in Q2 2022, an estimated $1K.
  • Money Concepts Capital first reported a position in Immunogen Inc in Q1 2022 and held it in 1 quarter.
  • Money Concepts Capital's Immunogen Inc position peaked at $1K in Q1 2022.
  • 216 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2022.

Based on Money Concepts Capital's 13F filing for Q2 2022, filed 18 Jul 2022.